Delivery Order SPE2DB22D2214-SPE2DB25FS2TB

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FETJ2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4564689906 - Lidocaine 5% Patch 30s, a pharmaceutical product, with a ceiling value of $8,082.49 and a completion date of May 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX9GC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The total ceiling value of the contract is $2,363.52, with a firm fixed price pricing type. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, with ID SPE2DB20D3111|SPE2DB24FA5YD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a ceiling value of $7,079.98 and a completion date of December 15, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX6JP, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with an ultimate completion date of December 3, 2024 and a ceiling value of $3,884.66. The contract is a Delivery Order under a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $4,939.84, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for 4,563,216,246 units of Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2024 and is a firm fixed-price type contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as...
This federal contract award, with the ID SPE2DB22D1202|SPE2DB25FUTU8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, and has a ceiling value of $1,319.40. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and the ultimate completion date is February 27, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, valued at $2,121.12, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FDUV1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product. The award has a ceiling value of $26,265.05 and a performance period ending on January 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM1W3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, and has a ceiling value of $2,087.58. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 9, 2024. It is not designated as a...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN31Y, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30S, a medical product, with a ceiling value of $1,005.20. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB25FS2TB
    Delivery Order

This federal contract award, with the ID SPE2DB22D2214|SPE2DB25FS2TB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, with a ceiling value of $1,648.26. This is a Firm Fixed Price Delivery Order contract, without any set-aside designation.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:07 PM